Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta‐analysis TA Furukawa, K Shinohara, E Sahker, E Karyotaki, C Miguel, M Ciharova, ... World Psychiatry 20 (3), 387-396, 2021 | 119 | 2021 |
Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults: A Systematic Review and Component Network Meta-Analysis Y Furukawa, M Sakata, R Yamamoto, S Nakajima, S Kikuchi, M Inoue, ... JAMA psychiatry, 2024 | 37 | 2024 |
Association between regional difference in heart rate variability and inter-prefecture ranking of healthy life expectancy: ALLSTAR big data project in Japan E Yuda, Y Furukawa, Y Yoshida, J Hayano, ALLSTAR Research Group Big Data Technologies and Applications: 7th International Conference, BDTA …, 2017 | 26 | 2017 |
Association of 24-hour heart rate variability and daytime physical activity: ALLSTAR big data analysis J Hayano, E Yuda, Y Furukawa, Y Yoshida Int. J. Biosci. Biochem. Bioinform 8, 61-67, 2018 | 25 | 2018 |
Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis Y Furukawa, Y Luo, S Funada, A Onishi, E Ostinelli, T Hamza, ... BMJ open 13 (3), e061023, 2023 | 21 | 2023 |
Optimal dose of aripiprazole for augmentation therapy of antidepressant-refractory depression: Preliminary findings based on a systematic review and dose–effect meta-analysis Y Furukawa, T Hamza, A Cipriani, TA Furukawa, G Salanti, EG Ostinelli The British Journal of Psychiatry 221 (2), 440-447, 2022 | 14 | 2022 |
Longer lying position causes lower LF/HF of heart rate variability during ambulatory monitoring Y Yoshida, Y Furukawa, H Ogasawara, E Yuda, J Hayano 2016 IEEE 5th Global Conference on Consumer Electronics, 1-2, 2016 | 11 | 2016 |
Amabié—A Japanese Symbol of the COVID-19 Pandemic Y Furukawa, R Kansaku Jama 324 (6), 531-533, 2020 | 10 | 2020 |
Optimal dose of brexpiprazole for augmentation therapy of antidepressant‐refractory depression: A systematic review and dose‐effect meta‐analysis Y Furukawa, S Oguro, S Obata, T Hamza, EG Ostinelli, K Kasai Psychiatry and clinical neurosciences 76 (9), 416-422, 2022 | 9 | 2022 |
Diagnostic accuracy of specific IgG antibodies for bird fancier’s lung: a systematic review and meta-analysis A Shiroshita, Y Tanaka, K Nakashima, Y Furukawa, Y Kataoka Annals of translational medicine 7 (22), 2019 | 9 | 2019 |
Understanding effect size: an international online survey among psychiatrists, psychologists, physicians from other medical specialities, dentists and other health professionals F Heimke, Y Furukawa, S Siafis, BC Johnston, RR Engel, TA Furukawa, ... BMJ Ment Health 27 (1), 2024 | 8 | 2024 |
Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review A Tajika, TA Furukawa, K Shinohara, S Kikuchi, R Toyomoto, Y Furukawa, ... BMJ Ment Health 26 (1), 2023 | 5 | 2023 |
Comparative efficacy and acceptability of treatment strategies for antipsychotic-induced akathisia: a systematic review and network meta-analysis Y Furukawa, K Imai, Y Takahashi, O Efthimiou, S Leucht Schizophrenia bulletin, sbae098, 2024 | 3 | 2024 |
Assessing the quality of cancer screening leaflets using the international patient decision aids standards instrument: a cross-sectional content analysis Y Furukawa, H Saito, K Hasegawa, M Ichikawa Patient Education and Counseling 104 (12), 3100-3103, 2021 | 2 | 2021 |
Characteristics of basal heart rate during daily life: Influences of age, gender, and seasons E Yuda, Y Furukawa, Y Yoshida, J Hayano Artificial Intelligence in Medicine 18, 2018 | 2 | 2018 |
Initial treatment choices for long‐term remission of chronic insomnia disorder in adults: a systematic review and network meta‐analysis Y Furukawa, M Sakata, TA Furukawa, O Efthimiou, M Perlis Psychiatry and Clinical Neurosciences 78 (11), 646-653, 2024 | 1 | 2024 |
Cognitive behavioral therapy for insomnia to treat major depressive disorder with comorbid insomnia: A systematic review and meta-analysis Y Furukawa, D Nagaoka, S Sato, R Toyomoto, HN Takashina, ... Journal of Affective Disorders, 2024 | 1 | 2024 |
Dismantling cognitive-behavioural therapy for chronic insomnia in adults with or without comorbidities: a systematic review and component network meta-analysis Y Furukawa, M Sakata, R Yamamoto, S Nakajima, S Kikuchi, M Inoue, ... medRxiv, 2023.05. 19.23290084, 2023 | 1 | 2023 |
Understanding the lung cancer mortality reductions produced by low-dose CT screening Y Furukawa The Lancet Regional Health–Europe 11, 2021 | 1 | 2021 |
Optimal dose of vortioxetine: High dose (≥ 20 mg) is overestimated, lower dose (5-10 mg) may be enough for many Y Furukawa Psychiatry and clinical neurosciences 78 (11), 726, 2024 | | 2024 |